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Abstract
Background: The present study reports the results of a survey jointly carried out by three Italian respiratory
scientific associations (AIMAR, AIPO, SIMeR) together with an important Federation of elderly patients (FederAnziani)
during the National Conference of Italian Court for Health Right held in Rimini from November 29th to December
1st, 2013. The survey, based on a spirometric examination preceded by a questionnaire on respiratory health, was
conducted on elderly people coming from all Italian regions to attend the Conference.
Methods: Nine hundred forty-nine subjects (574 females and 375 males), mean age 66.2 ± 10.1 years, were
interviewed and performed spirometric examination. There were 137 smokers (14.4 %). Mean value of Body Mass
Index (BMI) was significantly higher in males (27.6 ± 6.6) than in females (26.3 ± 4.3).
Results: 17.1 % (N = 143) of the studied subjects reported to be suffering from respiratory disease and the
prevalent illnesses were asthma (31.5 %) and COPD/emphysema (24.5 %), but only 3.3 % of the whole surveyed
group was able to identify COPD as a pulmonary disease, however without knowing its characteristics, while
these were known by 0.5 % of the interviewed subjects only.
A high number of subjects, 22 % of whom were smokers, declared chronic sputum production. 10.2 % of the
study group showed an obstructive defect at spirometry when the criterium of lower limit of the normal
(LLN) was considered, whereas it was 12.4 % if the fixed limit of 0.70 was chosen. 64 % of the obstructed
people thought they did not have any respiratory disease.
Conclusions: The results of this survey, able to spread the knowledge of respiratory diseases and spirometry
in a wide sample of subjects for the most part scarcely aware of them, emphasize the need for a greater
divulgation of respiratory issues among the general population.
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Background
Respiratory diseases represent the third cause of death in
28 states members of the European Community and
among them chronic obstructive pulmonary disease
(COPD) is the commonest one [1]. COPD is a heteroge-
neous condition, including chronic bronchitis, pulmonary
emphysema, and small airways disease, very often associ-
ated with extra-pulmonary complications and comorbidi-
ties which can increase the disease severity. It is also
characterized by a poorly reversible and progressive
airflow limitation associated with an airway inflammation
in response to noxious agents, mainly the cigarette smoke
[2, 3]. COPD is one of the main causes of disability-
adjusted life years (DALY) and its responsibility will
increase worldwide by 2030 according to World Health
Organization (WHO) [4, 5]. COPD patients refer a lower
quality of life compared to the normal and to healthy
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subjects of the same age [6]. Moreover, COPD is the only
chronic disease where a decreased life expectation has
been recorded (mortality increased 163 %, whereas
mortality for cardiovascular diseases varies from 35 % to
64 %). As a consequence, COPD still imposes a huge
sanitary, social and economic burden and in Europe the
indirect and direct costs of this disease are estimated as
high as 38.7 billions euro [7]. In Italy the annual cost of
COPD, including 2 or 3 medical consultations/year [8], is
2,110 euros per person and it almost doubles in case of
hospital admission due to exacerbation [9].
In spite of these facts, COPD is still rather unknown
and neglected not only by patients, but also by public
health institutions. Many studies also demonstrated that
patients can complain of symptoms but they frequently
do not refer to their general practitioner [10, 11], espe-
cially in the initial phase of the disease, so that COPD is
recognized when it has already reached a moderate/high
degree of severity [12–14]. Thus, it seems really import-
ant to reach an early diagnosis in order to avoid the dis-
ease progression towards more severe and disabling
stages, by means of a correct assessment of symptoms
and a spirometric examination. However, spirometry is
still underused not only in Italy [15], but also in other
countries, like Sweden where only 30 % of patients diag-
nosed suffering from COPD presented the results of a
spirometric examination in their health records [16], or
in U.S.A. where only 31 % of COPD patients admitted to
hospitals of care had performed a spirometric examin-
ation, while 78 % of those suffering from heart failure
had performed an echocardiography [17]. Spirometry is
poorly utilized to diagnose COPD also at general prac-
titioners (GPs) level [18, 19] likely due to a difficulty
in performing and interpreting the examination, to costs,
availability of services, long wait times for the examination
to be performed, and so on [20, 21].
In Italy there are not certain and updated estimates of
COPD prevalence, that is evaluated around 4.5 % [22] but
this is certainly an underestimation, as it is in other coun-
tries [23], thus it seems compelling to acquire more reli-
able data. With this aim the European Lung Foundation
(ELF) and the European Respiratory Society (ERS)
during their annual congresses from 2004 to 2009 or-
ganized the execution of spirometric examinations to
reveal early obstructive defects in general population
and recognize individuals at risk of developing COPD.
On a similar aim the survey devised and carried out
by the three Italian scientific respiratory societies
(AIMAR, Interdisciplinary Association for the study
of Respiratory Disease; AIPO, Italian Association of
Hospital Pneumologists; SIMeR, Italian Society of
Respiratory Medicine) together with the Federation of
elderly people (Federanziani) was based, whose results
are reported hereinafter.
Methods
Health Forum is an initiative promoted by FederAnziani
and carried out during the National Congress of Court
of Popular Justice for Health Right held in Rimini from
November 29th to December 1st, 2013. Among various
health projects, the above respiratory scientific societies
developed a project aimed at knowing respiratory dis-
eases, including a questionnaire and a spirometric exam-
ination, addressed to elderly people coming from
different Italian regions to attend the Congress. The
questionnaire included personal data, smoking habit,
clinical history with particular interest to respiratory dis-
eases, presence of predictive symptoms, and level of
knowledge of respiratory issues, mainly of asthma and
COPD. Spirometries were performed with Spirolab III
(Medical International Research srl, Rome, Italy), whose
characteristics are in accordance with the ERS/ATS stan-
dards [24]. The spirometric examination was performed
with the subject sitting and wearing a nose-clip. An ob-
structive defect was defined when FEV1/FVC (forced ex-
piratory volume in one second/forced vital capacity)
value was below the lower limit of normal (LLN) [25];
however also the fixed limit FEV1/FVC < 0.70 was used
to define the presence of obstruction due to the world-
wide use of this index especially in epidemiological stud-
ies. Based on FEV1 value as percent of the predicted (%
pred) the obstructive disease was classified in different
stages: stage I (FEV1 ≥ 80 % pred); stage II (FEV1 < 80 %
pred ≥ 50 %) ; stage III (FEV1 < 50 % ≥ 30 %); and stage
IV (FEV1 < 30 % pred) [26].
Statistical analysis was performed with MedCalc Soft-
ware version 11.3.0.0 (Acacialaan 22, B-8400 Ostend,
Belgium). Chi-square test was utilized to compare prob-
ability distribution of variables in the analyzed categor-
ies, and the test ANOVA to compare the variability into
the different groups with that among the groups. Data
are expressed as mean values. To evaluate the influence
of risk factors a multinomial regression analysis has been
conducted utilizing age decades, smoking habit, (current
smokers, ex-smokers, never smokers), gender, and inci-
dence of respiratory disease as independent variables,
and LLN with the different severity stages (I to IV) as
dependent variable.
Results
Characteristics of the study group
The study group includes 949 subjects (574 females
(60.5 %) and 375 males (39.5 %), with a mean age of
66.2 ± 10.1 years (range 22–89) for the whole group ;
mean age of females (65.3 ± 10.5 years, range 22–88)
was significantly (p < 0.001) lower than that of males
(67.7 ± 9.2, range 26–89). There were 339 (35.7 %)
subjects less than 65 years old, 242 (71.4 %) females
and 97 (28.6 %) males.
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Mean value of Body Mass Index (BMI) was significantly
(p < 0.001) higher in males (27.6 ± 6.6; range 18.6–43.3)
than in females (26.3 ± 4.27 ; range 16.8–43.6) (Table 1).
Results of the questionnaire
837 subjects, 301 (36.0 %) aged < 65 years, 536 (64.0
%) > 65 years, answered the question whether they
were suffering from respiratory disease and 143
(17.1 %) (n =143) gave a positive reply, while
among subjects aged less than 65 years, 46 (15.3 %)
answered to be suffering from respiratory diseases,
of which 60 in total were taking drugs. The main
reported respiratory diseases were asthma (n = 45;
31.5 %); COPD/emphysema (n = 35; 24.5 %) and
pulmonary fibrosis (n = 4; 2.8 %) (Fig. 1).
There were 523 (55.1 %) non smokers, 289 (30.5 %)
ex-smokers, and 137 (14.4 %) current smokers, mean of
14.4(±9.6) cigarettes/day, mean smoking duration 31.5
(±14.3) years. The majority of current smokers had tried
to give up smoking at least once, 75 % of them by
oneself, 10.3 % turning to a center for smoking cessa-
tion, 4.4 % assisted by their general practitioner, and
10.3 % in a different way.
632 subjects answered the question about COPD
knowledge, and 459 (72.6 %) out of them affirmed not to
know the disease, 149 (23.6) only knew the name of the
disease, 21 (3.3 %) were aware that COPD is a respira-
tory disease but were not able to describe the charac-
teristics of the disease, while only 3 subjects (0.5 %)
revealed a detailed and comprehensive knowledge of the
disease. The percentage of those who had a generic or
detailed knowledge of COPD was higher in the group
suffering from respiratory diseases (p = 0.044). The
results of the questionnaire concerning the presence of
predictive respiratory symptoms are shown in Table 2,
where the number of subjects reporting the presence of
chronic sputum production (22.4 % of whom were
current smokers) was very high.
Spirometry results
Data of 948 spirometries were examined : 85 subjects
(10.2 %) presented a FEV1/FVC rate lower than LLN,
and 58 out of them thought they were not suffering
from any respiratory disease (here indicated as “false
healthy” subjects). Among the subjects who knew to be
suffering from broncho-obstructive disease (FEV1/FVC
< LLN), 14 (51.9 %) had FEV1 > 80 % of the predicted
value, 11 (40.7 %) FEV1 between 79 and 50 % pred, and
2 (7.4 %) FEV1 < 50 % pred. Among the “false healthy”
subjects 45 (77.6 %) had FEV1 > 80 % pred, 13 (22.4 %)
FEV1 between 79 and 50 %. The results relative to dis-
ease severity with both methods of measure are reported
in Tables 3 and 4.
Forced vital capacity was not influenced by smoking
habit in our study group (mean value 104.0 ± 25.5 %
pred in non smokers + ex-smokers ; 101.4 ± 22.5 % pred
in current smokers; p = not significant), and it was
the same when the presence of respiratory disease
was taken as discriminant. On the contrary, mean
percent value of FEV1 was significantly reduced in
current smokers (97.0 ± 20.9 % pred) compared to
non smokers + ex-smokers (102.9 ± 22.1 % ; p = 0.004)
and in relation to the presence of respiratory disease
(p < 0.001). Similarly, the value of mean expiratory
flow was negatively influenced by smoking habit and
presence of respiratory disease. Comparing predictive
symptoms results and spirometric data, the percentage of
subjects complaining of frequent cough, chronic sputum
production, and wheezing also at night was more elevated
among those with FEV1/FVC < LLN (Table 5). Applying a
logistic regression model to individuate predictive symp-
toms correlated with the obstructive defect in the group
of “false healthy” subjects, the variables significantly cor-
related with the dichotomous index < or > LLN were: age
(mean age lower in subjects with FEV1/FVC < LLN,
productive cough (46.8 % in those with the rate lower than
LLN and 26.8 % in those with the rate greater than LLN);
wheezing under effort (6.6 % in < LLN and 9.0 % in the








Age 65.3 67.7 66.2 <0.001
Standard deviation 10.52 9.18 10.08
Median 66.0 68.0 67.0
Min - max 22–88 26–89 22–89
Age < 65 years 242 (42.2 %) 97 (25.9 %) 339 (35.7 %) <0.001
Age≥ 65 years 332 (57.8 %) 278 (74.1 %) 610 (64.3 %)
BMI 26.3 27.6 26.7 <0.001
Standard deviation 4.27 6.60 5.87
Median 25.9 26.6 26.3
Min - max 16.8–43.6 18.6–43.3 16.8–43.6
Fig. 1 Prevalence of the reported respiratory diseases in the
study group
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others), and wheezing at night (11.5 % in < LLN and 5.8 %
in the other group). The percentage of subjects com-
plaining of productive cough was significantly higher
(p = 0.002) in obstructed subjects compared to the
non-obstructed ones.
Discussion
The chronic and disabling diseases, among which COPD
holds a prominent position, are a serious social and eco-
nomic problem; in fact their incidence is increasing and
they are responsible for more than 35 millions of deaths
all around the world, also causing a relevant amount of
life years with disability conditions [27]. In Italy, respira-
tory diseases represent the third cause of death and their
prevalence is estimated to increase also due to the popu-
lation’s aging. Asthma prevalence is higher in females at
all ages except for the interval 15–34 years, while BPCO
is prevalent in males at all age ranges and this is more
evident in patients over 64 years old [28]. In our study
group, mainly composed of elderly people, the preva-
lence of respiratory diseases is more than 17 % and the
most frequent diseases are asthma and COPD in accord-
ance with the above mentioned national data. The in-
crease in chronic respiratory diseases is also influenced,
besides age, by the risk factors that sustain these dis-
eases. Direct and indirect costs of chronic diseases and
their consequences exert a significant weight on budget
of industrialized countries. Likely, a widespread know-
ledge of the basic issues of a certain disease would con-
tribute to reduce its incidence, to reach the diagnosis
earlier, and to increase patients’ adherence to treatment.
The aim of the present survey was to spread the
knowledge of respiratory diseases, COPD in particular,
in a wide random sample of elderly people coming from
different Italian regions to attend the Health Forum an-
nually promoted by FederAnziani in Rimini.
Questionnaires and spirometric examinations yielded
interesting results and, if some well established concepts
are confirmed, notably important elements are suggested
for further intervention aimed at diffusing the know-
ledge of chronic respiratory diseases and improve
their diagnosis.
In this respect, the answers to the question concerning
the meaning of the COPD acronym and the knowledge
of the characteristics of this disease are very significant.
In fact, only 3 out of 632 interviewed subjects were
aware of COPD characteristics and other 15 subjects
were able to clearly define COPD as an obstructive
airways disease. This, likely, indicates a lack or insuffi-
ciency of communication concerning the characteristics
of COPD, a potentially disabling and highly resource-
consuming disease, among the general population. A
campaign aimed at sensitizing population through au-
diovisual means of communication is at least advisable
to make people understand the importance of abolishing
risk factors and reaching an early diagnosis in order to
reduce COPD incidence and its progression.
The main predictive symptoms reported in this study
are chronic sputum production and dyspnea also under
minimal efforts. COPD generally presents with persist-
ent cough, continuous sputum production and dyspnea
but these symptoms are often overlooked especially by
smokers at initial stages of the disease, because they do
not consider these symptoms as a marker of illness but
only an unavoidable consequence of smoking. Thus, the
diagnosis is delayed and obtained when the disease already
has reached greater severity with important and irrevers-
ible pathologic and functional consequences and increased
social and economic burden.
It is well established that cigarette smoking is a main
cause of COPD origin, and the etiologic COPD fraction
attributable to smoking varies from 70 % to 80 % in
several studies [29]. In the present survey only 137
Table 2 Distribution of answers to questionnaire concerning predictive symptoms of respiratory disease
Symptoms of respiratory disease YES NO % Positive answers
Do you cough frequently? (796 answers) 173 623 27.8
Do you frequently have sputum production with cough? (802 a.) 281 521 53.9
Do you complain of dyspnea under mild efforts? (808 a.) 278 530 52.4
During physical activity do you have more shortness of breath than your companions of the same age? N = 764 278 496 56
Do you perceive wheezing in your chest when you breathe under effort? (792a.) 113 679 16.6
Do you perceive wheezing in your chest when you breathe at night? (599 a.) 69 530 13
Do you frequently catch a cold lasting more than that of other people you know? (811 a.) 186 625 29.8
Table 3 Results of spirometric examination: number of
subjects with airways obstruction using the fixed value of
0.70 or the LLN
FEV1/FVC <0.70 FEV1/FVC < LLN
Tot. 104 85
“False Healthy”a 67 58
Patientsb 37 27
a”False healthy” = Subjects with obstructive defect who thought to be healthy
bPatients = Subjects with obstructive defect aware to be suffering from
respiratory disease
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subjects (14.4 % of the 949 interviewed subjects) de-
clared to be current smokers. This prevalence of
smokers is lightly higher than that recorded on the
average in Italian population of the same age. In fact,
data published this year by the Italian Observatory for
Smoking, Alchol, and Drug (OSSFAD) report in general
20.8 % of smokers (25.1 % in men and 16.9 % in
women), but a mean of 9.9 % (14.2 % in men and 6.7 %
in women) in subjects 64 years old or more and 18.3 %
in the age range 45–64 years [30]. Likely, the mean
percentage of smokers is higher in our study group
because more than one third of subjects were less than
65 years old.
The first reference for an effective action against
smoking are GPs who should always record the smoking
condition in every assisted patient, besides the amount
of smoked cigarettes, and the duration of this practice.
Indeed, this does not always happen because a wide
inquiry at GPs’ level revealed that only 53 % of them
know how many smokers or ex-smokers are in the
whole group of patients they assist, and only about 30 %
applied an even minimal counselling protocol to favor
smoking cessation [21]. These data are in accordance
with the fact that in the present study the majority of
smokers who affirmed having tried to give up smoking
did it by themselves, less than 5 % with the GP assist-
ance, and about 10 % turning to a smoking cessation
center. Furthermore, an intervention with greater effect-
iveness for adolescents to not start smoking and adult
smokers to give up smoking is really essential to prevent
not only respiratory diseases, but also other chronic
diseases that can cause death and disability [31].
About 10 % of subjects who underwent spirometry in
this study presented an obstructive defect of various en-
tity and this can be related to the fact that asthma and
COPD together are present in 10 % of the whole group.
The incidence of airways obstruction in our patients is
lower than that observed in the spirometry project on
general population carried out by ERS where a 12.4 % of
obstructed subjects using the LLN index and 20.3 %
using the fixed ratio 0.70 were recorded. In several stud-
ies carried out by GPs especially in smokers, the inci-
dence of obstructive defect at spirometry varies from
22.2 % in a Belgian study to 29.9 % in another investiga-
tion performed in Holland [32, 33]. However, what
seems rather alarming is that 70 % of subject with air-
ways obstruction in our survey thought they did not
have any respiratory disease. This can be explained with
Table 4 Results of spirometric examination: subjects distribution in relation to severity of obstruction and method of
obstruction assessment
FEV1/FVC < LLN “False healthy”
a FEV1/FVC < LLN Patients
b FEV1/FVC < 0.70 “False healthy”
a FEV1/FVC < 0.70 Patients
b
FEV1 ≥ 80 % 45 14 52 22
FEV1 < 80 ≥ 50 % 13 11 15 13
FEV1 < 50 % 2 2
a”False healthy” = Subjects with obstructive defect who thought to be healthy
bPatients = Subjects with obstructive defect aware to be suffering from respiratory disease
Table 5 Predictive symptoms of respiratory disease in relation to the presence of obstructive defect at spirometry
Symptoms of respiratory disease Percentage of subjects answering yes to the question p
FEV1/FVC < 70 or < LLN Normal spirometry results
Do you cough frequently? N = 108 N = 687 0.008
34 (31.5 %) 139 (20.2 %)
Do you frequently have sputum production with cough? N = 113 N = 688 0.002
54 (47.8 %) 226 (32.8 %)
Do you complain of dyspnea under mild efforts? N = 113 N = 694 0.368
43 (38.1 %) 234 (33.7 %)
During physical activity do you have more shortness of breath than your
companions of the same age?
N = 109 N = 654 0.177
46 (42.2 %) 232 (35.5 %)
Do you perceive noises in your chest when you breathe under effort? N = 115 N = 676 0.029
28 (20.9 %) 89 (13.2 %)
Do you perceive noises in your chest when you breathe at night? N = 92 N = 506 <0.001
21 (22.8 %) 48 (9.5 %)
Do you frequently catch a cold lasting more than that of other
people you know?
N = 114 N = 696 0.065
34 (29.8 %) 153 (22.0 %)
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the fact that the majority of them presented a mild or, in
some cases, moderate obstructive defect, thus they gave no
importance to the possible limiting effects of the obstruc-
tion or to the predictive symptoms, especially if smokers,
and did not seek medical consultation neither had ever per-
formed a spirometric examination.
Thus, our findings that confirm the negative influence
of cigarette smoking on respiratory function make once
more really urgent the need for organizing the fight
against smoking at any level better than how already done.
In our study also the value of predictive symptoms is
clearly confirmed by comparing the incidence of symptoms
in subjects with airways obstruction and those without
obstruction. Moreover, respiratory symptoms were present
in 50.4 % of 125 smokers and in 34.7 % of 677 non smokers
(p < 0.001). Presence of chronic cough and sputum produc-
tion is significantly increased in the group of subjects with
airways obstruction and the predictive value of disease and
possible airways obstruction inherent to these symptoms,
especially chronic cough, is confirmed also in the group of
obstructed patients who thought to be healthy.
Presence of dyspnea for mild efforts in our sample of
subjects does not seem to correlate with the respiratory
function defect, at least with the simple measurement of
FEV1/FVC; however it cannot be excluded the responsi-
bility for the determinism of this symptom of cardiovas-
cular diseases alone or associated with the respiratory
ones, possibly revealable with more sophisticated func-
tional examinations.
Conclusions
Clinical and instrumental respiratory assessment of a wide
sample of elderly population coming from all Italian
regions allowed to point out some interesting aspects, first
to highlight that the incidence of chronic respiratory
diseases is very high (more than 17 %) in general popula-
tion at this age. The negative role of smoking in terms of
respiratory function defect and the predictive value of
some key symptoms like chronic cough and sputum
production were confirmed.
This survey has represented a unique opportunity to
spread the knowledge of respiratory diseases and spiro-
metric examination in a wide amount of subjects for the
most part unaware of them, and the results emphasize
the need to increase the divulgation of respiratory issues
in order to improve life style, mainly in relation to smok-
ing habit, and possibly reach an earlier diagnosis of re-
spiratory disease when it would be still possible to slow up
the structural alterations and the functional decline.
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